Optifast Review: Does it Work?

Program offers 12 weeks of meal replacement to help you lose weight.

Business News
The shareholders demanded that Mr. They refused to turn the shipment around or to take it back and are trying to create some kind of lie that I created a 2nd account in November and they only cancelled one account. Dehydrated milk that is added to foods due to its naturally long preservation. He threatened to nominate a new slate of independent directors for election at the next shareholder meeting, in May, if they refused The provided content on this site should serve, at most, as a companion to a professional consult.

User Feedback

Weight Watchers Online Plus Reviews - What Is It?

You must refuse to deal with any merchant or shopkeeper who sells any German-made goods or who patronises German ships or shipping There are reasons for the assumption that our share in this fight is of general importance. We shall start a spiritual and material war of the whole world against Germany. Germany is striving to become once again a great nation, and to recover her lost territories as well as her colonies.

But our Jewish interests call for the complete destruction of Germany The Jews owned the largest and most important Berlin newspapers, and made great inroads on the educational system. The goal of Judaism of today is: We demand a complete blockade of trade, the importation of raw materials stopped, and retaliation towards every German, woman and child.

A will be formed to bring the German and Italian economic systems to their knees. Israel has been attacked. Let us, therefore, defend Israel! Against the awakened Germany, we put an awakened Israel. And the world will defend us. November "The millions of Jews who live in America, England and France, North and South Africa, and, not to forget those in Palestine, are determined to bring the war of annihilation against Germany to its final end. We wish to do so in a way entirely consonant with the general scheme of British action, and therefore would place ourselves, in matters big and small, under the co-ordinating direction of His Majesty's Government.

The Jewish Agency is ready to enter into immediate arrangements for utilizing Jewish manpower, technical ability, resources, etc. Few papers will risk any attack on the Jews, however well-founded, for fear of appearing even distantly anti-Semitic. Twenty-five percent of the inhabitants of New York are Jews.

During the Great War we bought off this huge American Jewish public by the promise of the Jewish National Home in Palestine, held by Ludendorff to be the master stroke of Allied propaganda as it enabled us not only to appeal to Jews in America but to Jews in Germany as well. Stronger than all fronts together is our front, that of Jewry.

We are not only giving this war our financial support on which the entire war production is based. We are not only providing our full propaganda power which is the moral energy that keeps this war going. The guarantee of victory is predominantly based on weakening the enemy forces, on destroying them in their own country, within the resistance. And we are the Trojan Horses in the enemy's fortress.

Thousands of Jews living in Europe constitute the principal factor in the destruction of our enemy. There, our front is a fact and the most valuable aid for victory. The Soviet State Publishing House is preparing the publication of another "Black Book," a documentary record of the German massacre of approximately six million European Jews.

According to the Soviet editors, the Germans killed between five and six million Russian, Polish and Western European Jews, and an additional half million are being murdered in Hungary now. The war time Premier Winston Churchill said he thought the problem of a National Jewish Home in Palestine was too big to be handled by one single nation alone. I said at once, "The Unnecessary War. And Germany gave them refuge. And they were treated very nicely.

And here they sold Germany down the river for no reason at all other than they wanted Palestine as a so-called "Jewish commonwealth. There was no sentiment against those people merely on account of their religious belief. It was all political. It was anything but religious When Germany realized that the Jews were responsible for her defeat, they naturally resented it. But not a hair on the head of any Jew was harmed. Posted by Chris Moore at 3: Introduction by Chris Moore -- This is an interesting discussion vis-a-vis The new anti-Semitism, and the campaign to silence American critics of Israel by Jeff Warner and Dick Platkin on the Mondoweiss blog regarding the authors' claim that Jewish students and faculty were once victims of real anti-Semitism on American campuses from the early 20th Century through the early s in the form of admission quotas, glass ceilings on high academic and administrative positions, and discriminatory practices by fraternities and sororities.

The discussion took place in the Comments section of the blog. I found it interesting because I too was skeptical of the veracity of this particular claim, and suspect it's just another of those mythical Jewish victim shtick narratives that gets handed down over generations, exaggerated a little bit more each time it's handed off kind of like what became known fist as the Holocaust and then to distinguish the Jewish angle even further, the Shoah I've long wondered if it wasn't an anti-Catholic, Zionist strain of Protestantism perhaps in conjunction with self-evidently Catholic-hating Zionist Jews who forever declare that "Hitler was a Catholic!

Kennedy, in part because he was not on board the exaggerated "evil Germany" and "evil Western Civilization" Zionist-Marxist-Imperialist victim-shtick narrative, and in fact in the wake of WWII expressed tremendous compassion for the German people, and was highly critical of Russian and British looting, pillaging and raping, and even somewhat critical of U. No doubt the warped, vengeance-seeking, Zionist strain of Protestantism always held that against him.

Here's part of the Comments section discussion that emphasizes this Zionist anti-Catholicism in particular: August 26, at 1: Just a ridiculous statement.

In fact, there were no real quotas affecting Jewish students during these years— there were attempts at lots of elite universities to make them more nationally focused universities, by taking students from the other 40 states of the union, not huddled around the Northeast corridor.

That is, there was positive discrimination for kids from the states that people in the Northeast have always hated Alabama, Arkansas, Texas, Oklahoma, etc , and as a result, many Jews living in the Northeast complained that this was pro-Christian discrimination or anti-Jewish discrimination in the same way that whites currently complain about affirmative action.

More recently there is a fervent anti-Muslim fervor among lots of atheists and Jewish profs at elite universities— the same type of people that are anti-Catholic are often equally anti-Muslim. August 26, at 4: And I do not know why the authors rolled that old dog out in their essay. Either they have an interest in keeping the untrue meme alive or they have been brainwashed to believe it and keep on repeating it. I think the latter. I think it was Galbraith who said that is is still and always PC in America to be completely anti Catholic.

All that is really besides the point — and so what — as what I wonder is why it seems there is a celebration, even a nurturing of ideas of anti Jewish in history as a part of Jewish identity?

What other group does that? And why would any group do so? August 26, at 6: This is what Madrid mentioned, but from what the jewishvirtuallibrary says there was also anti-semitism at work. I see no reason to doubt it. American Christians have about as little to complain about as any group in history—just some ridicule by secularists in Hollywood sometimes—and evangelicals sometimes talk like mass persecution is just around the corner.

Every group that has suffered anything claims victim status, some with more justification than others. Even white males in the US get into the act sometimes.

Whether the attempt to grab moral high ground is justified is just something one has to figure out on a case-by-case basis. As for the rest of your post, it is too banal and ridiculous to respond to, but briefly. That is, after all, essentially weak and pathetic. I witnessed Muslin women in the Balkans removing a plaque placed in the memory of the horrific rapes and killings in a sports stadium. This was not the self identity they wanted to cultivate and nurture.

As for the Christian fear about mass persecution right around the corner: August 26, at 7: A review of that history shows that most of the charges of American anti-Semitism at elite American universities, while certainly valid in some cases, were exaggerated.

Here are a few salient facts about the history of religious elites in England and the US after the seventeenth century that should make things clearer: After , when the Puritans and the Levellers got control of England, the country became very philo-Semitic, something which did not change with the restoration of the king in It was also that the Puritans thought of themselves as the New Jews— the new Chosen nation.

This was caused partly by the Erastian political theories that had begun in the earlier century, but it was also due to the new focus on the Old Testament by the Puritans, rather than the New Testament.

During this period and later, it was often said by English and American Protestants of all denominations that it was far more important to fight the Catholics than the Jews or the Muslims. Indeed, even Queen Elizabeth had tried to establish strong diplomatic relations with the Sultan of the Ottoman empire, at a time when Europe was seriously threatened with wholesale invasion by the Ottomans. This is because Anti-papism was a fundamental aspect of Protestantism and still is to some degree.

It was a basic requirement of being a good protestant, and thus expression of anti-papism became a fundamental aspect of the religion. This never occurred with anti-Semitism— in fact, many Puritan sects tried early on to emulate the Jewish prohibition on eating pork, for example, while everything to do with Catholic traditions was to be rejected.

And they thought that Catholics recognition of the Pope meant that Catholics were ipso facto traitors to the country. At least before the state of Israel was founded, there was no evidence of Jewish dual loyalty for American Protestants, so there was no reason to make accusations of dual loyalty during the first 5 decades of the 20th century.

So while, yes, there was certainly anti-Semitism, Jews were accepted in the historically Protestant universities of the Northeast well before Catholics were accepted at those places. A good example of how serious anti-Catholicism was at the university level is the contempt that the University of Notre Dame encountered, when Knute Rockne tried to lobby for ND to join the Big Ten conference.

Even though Notre Dame had rivalries with several of the Big Ten schools, administrators at Michigan and Chicago said very publicly that in no uncertain terms would there ever be a Catholic school in the Big Ten. There never has been such outward hostility to any other religion in the US, including Judaism, with the exception of recent hostility towards Islam. Earlier in his career, Dr. Litwin earned his M. Steve Herne, an experienced sales and business development executive in both technology and services, joined MedAvante-Prophase as Chief Commercial Officer in July with overall responsibility for sales and marketing.

Prior to his appointment, he was Chief Commercial Officer, eHealth Solutions at Bioclinica, a provider of clinical trial management solutions. Herne began his career as a Senior Research Scientist for Inveresk Research before moving to a business development position at Quintiles and then returned to Inveresk as Senior Business Development Manager. In that position, he led the planning and implementation of a finance reorganization process.

Downing also lent support to responsibility, strategy, capital investment, expansion and financial training. In addition, he led a team responsible for the overall financial health of projects, including profitability, revenue recognition, cash flow, invoicing, and financial training for project managers and their teams. Before joining Covance, Mr. Greg Barrett leads worldwide software and platform development for MedAvante-ProPhase, supporting clinical science and signal detection capabilities.

He joined the company in April , bringing 30 years of information technology experience. In his role as Global IT Leader for Covance, he oversaw team members supporting five business units with applications, architecture, business engagement and computer systems validation. As Vice President of Regulatory and Quality Assurance since she has been responsible for evaluating activities of regulatory significance and ensuring that quality standards and regulatory requirements are implemented and maintained throughout the organization while leading audit teams in successful completion of more than 60 customer audits without a single significant finding.

Widely recognized for her achievements in organizational leadership, Ms. Wilmer is often sought for advice and collaboration and asked to share her expertise with professionals worldwide through networking and consulting.

Wilmer worked for more than 20 years in health care where she developed expertise in regulation interpretation.

At Horizon Blue Cross Blue Shield of New Jersey, she successfully developed and managed health care policies and administrative procedures to ensure compliance with regulatory agencies and other standards for a network of over 10, providers.

She has developed recruitment, contracting, and retention strategies for employees, physicians, and ancillary providers. He also has a strong background and interest in psychometrics and neurocognitive assessment, having worked for over 20 years as a consultant on test development, including the revisions of the Wechsler intelligence and memory scales.

Randolph is Clinical Professor of Neurology and Director of the Neuropsychology service at Loyola University Medical Center and is board-certified in clinical neuropsychology. Before joining MedAvante-ProPhase in July , he held the position External Clinical Innovation Leader at Roche, where he was responsible for developing, integrating and operationalizing strategic innovations throughout drug development.

Prior to that post, he was Vice President, Project Management, Americas for the clinical research organization PRA HealthSciences, leading a team of clinical research professionals covering all therapeutic areas.

He also held senior project management and operations posts at Worldwide Clinical Trials, Inc. Cioffi holds the B. Detke is a psychiatrist with more than 20 years of research experience and extensive clinical and drug development expertise. This role included registration and regulatory commitment trials for Cymbalta, including major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia and chronic pain, as well as pediatric trials.

Detke teaches and supervises medical students and residents as Clinical Professor of Psychiatry at Indiana University School of Medicine. He trained in medicine and psychiatry at Harvard Medical School and at the Mt.

Detke has published more than 60 manuscripts in peer-reviewed journals since Williams has more than 30 years of clinical research experience in both industry and academia. She is now Professor Emerita at Columbia University. Williams is well known in the field for her development of psychiatric classifications and instruments to measure psychopathology. She is the author of more than scholarly publications and serves on the editorial boards of several psychiatric and social work journals.

She has received numerous awards for her achievements and contributions in social work and psychiatry. His research groups also led development programs for the analgesic drug tapentadol, the long-acting antipsychotic agent paliperidone palmitate, and other potential treatments for CNS disorders. Kobak is a psychologist with more than 30 years of clinical research experience in both industry and university medical settings.

Throughout his career, he has focused on clinical assessment, rater training, rating scale development and clinical trials methodology. Kobak founded the consultancy Research Training Associates, where he developed new methodologies for training and calibrating raters in clinical trials using digital technologies. Kobak managed a clinical trials unit and pioneered the use of computer-administered rating scales in clinical trials.

He authored computer-administered versions of several clinician-administered rating scales, including depression and anxiety scales that are widely used today, and a computer-administered version of the PRIME-MD, a diagnostic interview that was published in JAMA.

Kobak received several NIMH grants to develop and study rater training methodology for depression, schizophrenia, and autism. Negash serves as the scientific lead bridging research and operations to ensure MedAvante-ProPhase clinical trial services are implemented successfully from a scientific and service delivery perspective. Her work has focused on investigating factors associated with successful cognitive aging, including lifestyle factors such as cognitive activity, and on developing interventions that enhance cognitive fitness in older adults.

She also studies successful cognitive aging in minority populations, particularly African-Americans. Her other area of work focuses on examining implicit and explicit learning and memory systems in healthy aging and in mild cognitive impairment. Kane has been the principal investigator for research projects focusing on schizophrenia, psychobiolgy and treatment, recovery, and improving quality and cost of care.

He is the author of over peer-reviewed papers and serves on the editorial boards of numerous journals. Sue Vallow is a patient-reported outcomes PRO scientist with more than 20 years of experience developing and implementing patient-focused outcomes strategies and capabilities in numerous therapeutic areas with a specialty in CNS trials.

She is a co-author of more than 20 peer-reviewed papers and more than 70 research posters and presentations. Sofija Jovic is focused on the strategic combination of MedAvante-ProPhase as the thought leader in using measurement science and data quality to transform clinical trials. Jovic guided the transformation from a four-person start-up to a global industry leader in collaboration with ProPhase founder Dr. Jovic started her career as a clinical psychologist: Jovic has published in peer-reviewed journals and presented scientific papers at professional and industry conferences.

His academic research focuses on the etiology, phenomenology, and treatment of serious and persistent mental disorders. He has co-authored over 40 peer-reviewed publications and has contributed to multiple book chapters and review articles on schizophrenia and mental health research.

Lord-Bessen oversees MedAvante-ProPhase Clinical Data Analytics services including data management, statistics, and psychometric activities, including consultation on the development and validation of new Clinician-Reported and Patient-Reported Outcomes as well as the conversion of existing assessments to electronic format. Lord-Bessen has over twenty years of experience in statistics and measurement. Twelve board members from leading universities and research institutions provide counsel and guidance to MedAvante-ProPhase on initiatives relating to mood, anxiety, schizophrenia, and other psychiatric disorders.

Co-chaired by John M. Richard Feinberg Chair in Schizophrenia Research. Eleven top leaders from major Japanese universities and research institutions provide their expertise to enhance the ability to collect high-quality research data with less error and greater signal detection. At MedAvante-ProPhase, we look for colleagues who combine talent with a powerful desire to change healthcare for the better and ensure that effective therapies make it to the patients who need them.

This is the mission uniting the clinicians, scientists, technologists, and operations experts whose mix of energy, inventiveness, and skill drives not only MedAvante-ProPhase but the entire WIRB-Copernicus Group family of companies in a relentless quest to improve clinical trials.

What do you do at MedAvante-ProPhase? As a member of the Business Development team, I am responsible for overseeing the creation of our responses to requests for information and proposals from drug development sponsors planning clinical trials.

I also serve as a subject matter expert on clinical and technical aspects of our service solutions. Why did you decide to work at MedAvante-ProPhase? What do you like best about your job? MedAvante-ProPhase lacks the layers of hierarchy that can kill good ideas or contributions from different departments, and our entire team is determined to stay on the forefront of signal detection and clinical trial technology.

What are your colleagues like? Hard working, open and approachable. They like to be challenged, and they constantly push the limits of their comfort zone to ensure that quality of service is the first thing any customer remembers. What impact has working at MedAvante-ProPhase had on you?

My job is to perform live clinical psychiatric interviews by phone and video conferencing with study subjects participating in clinical trials. I also review documents and recordings of neuropsychological and psychiatric assessments conducted by other clinicians to provide feedback on scoring and administration. I found in MedAvante-ProPhase a great place to use my behavioral health experience in a clinical trials setting, as well as a perfect fit for my years of face-to-face counseling, neuropsychological assessments, and phone work at an employee assistance program provider.

I like the excellent training, as well as the opportunity to work with a dedicated group of professionals. I have worked a number of places in my career before MedAvante-ProPhase but I never met a more caring and dedicated group of employees as I have here. While I work in the office, I feel just as connected to my peers who work remotely.

The learning at MedAvante-ProPhase for me started on day one, and has never stopped. As the company grows, so does my ability to gain further skills as a clinician and professional in different research areas. I administer the adjudication process for large global studies by tracking cases, contacting sites for needed information, and assembling and storing the required documentation.

I come from the medical field, having graduated as a Medical Doctor in Dominican Republic. I really love the flexibility that makes my work very convenient for me and my family. I also like the way our multicultural team all treats each other with respect and I enjoy working with colleagues from around the world. In our department we are very diverse in culture, beliefs and opinions, but there is something common in all of us and that is the respect and the compassion we all have.

My colleagues really care about each other and are willing to help and support. Working here has helped me take personal responsibility for learning and development, and increased my understanding that there is a lot more to do in the pharma world. I interact with people from all over the world in my job, exchanging information, optimizing various processes, and, most importantly, providing high quality technical support and customer service to our clinical trial sites.

The nature of our work is such that I am constantly learning new things, and I must steadily exercise and develop my skills. When I first came across the MedAvante-ProPhase job opening, I knew the skills I had acquired during my career up to that point would make me a strong candidate. On the other hand, medical research was a completely new field for me. Therefore, the job was both a good fit and a big challenge for me. I had to apply. Every day is interesting and challenging, it might be a bit hard, but it is never boring.